Genmab AS (GMAB)
21.21
-0.46
(-2.12%)
USD |
NASDAQ |
Nov 14, 16:00
21.21
0.00 (0.00%)
After-Hours: 18:44
Genmab Total Liabilities (Quarterly): 1.159B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.159B |
| June 30, 2024 | 1.098B |
| March 31, 2024 | 605.09M |
| December 31, 2023 | 546.23M |
| September 30, 2023 | 584.36M |
| June 30, 2023 | 470.33M |
| March 31, 2023 | 469.01M |
| December 31, 2022 | 408.32M |
| September 30, 2022 | 532.52M |
| June 30, 2022 | 420.35M |
| March 31, 2022 | 329.39M |
| December 31, 2021 | 370.09M |
| September 30, 2021 | 421.23M |
| June 30, 2021 | 357.03M |
| March 31, 2021 | 333.36M |
| December 31, 2020 | 334.21M |
| September 30, 2020 | 480.12M |
| June 30, 2020 | 424.20M |
| March 31, 2020 | 133.66M |
| December 31, 2019 | 164.31M |
| September 30, 2019 | 119.53M |
| June 30, 2019 | 105.24M |
| March 31, 2019 | 91.30M |
| December 31, 2018 | 68.48M |
| September 30, 2018 | 50.50M |
| Date | Value |
|---|---|
| June 30, 2018 | 52.50M |
| March 31, 2018 | 43.48M |
| December 31, 2017 | 53.30M |
| September 30, 2017 | 67.80M |
| June 30, 2017 | 90.63M |
| March 31, 2017 | 57.37M |
| December 31, 2016 | 58.53M |
| September 30, 2016 | 63.05M |
| June 30, 2016 | 56.77M |
| March 31, 2016 | 59.28M |
| December 31, 2015 | 60.91M |
| September 30, 2015 | 69.68M |
| June 30, 2015 | 77.29M |
| March 31, 2015 | 85.11M |
| December 31, 2014 | 136.13M |
| September 30, 2014 | 152.96M |
| June 30, 2014 | 177.00M |
| March 31, 2014 | 189.17M |
| December 31, 2013 | 198.42M |
| September 30, 2013 | 232.25M |
| June 30, 2013 | 206.16M |
| March 31, 2013 | 217.68M |
| December 31, 2012 | 232.13M |
| September 30, 2012 | 243.06M |
| June 30, 2012 | 167.86M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
133.66M
Minimum
Mar 2020
1.159B
Maximum
Sep 2024
482.05M
Average
422.72M
Median
Total Liabilities (Quarterly) Benchmarks
| Novo Nordisk AS | 41.48B |
| Ascendis Pharma AS | 1.157B |
| Galecto Inc | 2.441M |
| Evaxion Biotech AS | 15.18M |
| IO Biotech Inc | 15.20M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.940B |
| Shareholders Equity (Quarterly) | 4.781B |
| Current Ratio | 5.169 |